Forget Mylan: The Government Should Immediately Investigate Mallinckrodt
By Christopher Irons for GeoInvesting Mallinckrodt's Acthar Gel may turn out to be the most appalling story in all of [...]
Marina Biotech – MRNA: A Forgotten And Grossly Undervalued Game Changer
Summary Trading at less than a quarter of valuation of its closest peer that was acquired by Roche in August [...]
Ibio (AMEX:IBIO) – Claims Exclusive Rights in Certain Anti-Ebola Antibodies and Vaccines
Ibio (AMEX:IBIO) Price Movement From Ebola/Enterovirus Hype Ibio (AMEX:IBIO) ($1.47) is a leading provider of plant-based biotechnology for developing and manufacturing biological products. [...]
Protected: GeoTeam News 9/18/2014 >> XXII, VNET, CTRP, ZOOM, BSPM, HOLI, MOBI
This content is password protected. To view it please enter your password below: Password:
22nd Century Group, Inc. (XXII) – Further Dilution after Rebuttal
22nd Century Group, Inc. (XXII) - Closed a $10 million private placement adding to dilution We will look to add to [...]
Thermal Tennis Inc ( OTCCB: TTNS) – medical cannabis dispensary business
Thermal Tennis Inc (OTCCB:TTNS) - CannaSys was originally organized as a Colorado limited liability company in October 2013 and converted [...]
Sciclone Pharmaceuticals ( NASDAQ: SCLN) – first intervention oncology product
Sciclone Pharmaceuticals (NASDAQ:SCLN)($6.79) - and its partner BTG plc (LSE: BTG), today announced, that the China Food and Drug Administration [...]
GeoTeam News 8/28/2014 >> XXII, DGLY, VII, ISNS, NHTC, VRYAF, CREG, LAS, ONP, SCLN, GOMO, SGOC, VNET, CCUR, IG
Call(s) to Action: XXII, DGLY, NHTC, VRYAF The GeoTeam offers it own rebuttal to XXII’s response to GeoInvesting’s article, “22nd [...]